Related Experiment Video
Updated: May 2, 2026

08:20
Author Spotlight: AI-Driven Trypanosome Species Detection from Microscopic Images
Published on: October 27, 2023
2.9K
Reframing AI for Rare Disease Recognition
Wei-Qi Wei1, Chao Yan1, Wu-Chen Su2
1Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, TN, USA.
Research Square
|April 10, 2026
Summary
GEN-KnowRD accelerates rare disease recognition by using large language models to build knowledge bases, improving diagnostic accuracy and reducing delays for patients. This framework enhances screening and early discrimination from health records.
Area of Science:
- Computational biology
- Medical informatics
- Genomics
Background:
- Rare diseases impact over 300 million globally, with diagnostic delays hindering timely treatment and research participation.
- Current computational rare disease recognition (RDR) methods struggle with incomplete and heterogeneous knowledge resources, requiring extensive expert curation.
- Direct application of large language models (LLMs) for diagnosis faces knowledge bottlenecks and raises concerns about cost, reproducibility, and data governance.
Purpose of the Study:
- To introduce GEN-KnowRD, a novel framework that leverages LLMs to construct a computable knowledge base for rare disease recognition.
- To evaluate GEN-KnowRD's performance in general-purpose rare disease screening and early discrimination using longitudinal electronic health records.
- To demonstrate the benefits of a knowledge-layer-first approach in RDR, decoupling knowledge generation from patient-level inference.
Main Methods:
- GEN-KnowRD utilizes LLMs to generate schema-guided rare disease profiles and assesses their quality.
- A computable knowledge base, PheMAP-RD, is constructed for local deployment.
- Lightweight inference pipelines integrate this knowledge for disease screening and early discrimination from electronic health records.
Main Results:
- GEN-KnowRD significantly improved disease ranking in general-purpose screening benchmarks (up to 345.8% improvement vs. HPO-centered framework).
- The framework outperformed advanced end-to-end LLM reasoning (up to 129.1% improvement) and expert-curated knowledge variants.
- In a real-world idiopathic pulmonary fibrosis cohort, GEN-KnowRD showed robust gains in early discrimination performance.
Conclusions:
- Repositioning LLMs to the knowledge layer enhances rare disease recognition (RDR) performance.
- GEN-KnowRD provides a scalable, updatable, and reusable infrastructure for rare disease diagnosis, screening, and research.
- This approach addresses limitations of existing RDR methods, offering improved accuracy and efficiency.
Related Concept Videos
iPS Cell Differentiation
2.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
2.2K
Pharmacogenomics: Identification of New Drug Targets
121
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
121
